These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 21686325)
1. Coordinated gene expression of Th17- and Treg-associated molecules correlated with resolution of the monophasic experimental autoimmune uveitis. Jia X; Hu M; Wang C; Wang C; Zhang F; Han Q; Zhao R; Huang Q; Xu H; Yuan H; Ren H Mol Vis; 2011; 17():1493-507. PubMed ID: 21686325 [TBL] [Abstract][Full Text] [Related]
2. Longdan Xiegan Decoction alleviates experimental autoimmune uveitis in rats by inhibiting Notch signaling pathway activation and Th17 cell differentiation. Yin X; Qiu Y; Li Z; Guo L; Wei H; Liu B; Zhou M; Li T; Wang L; Jiang W; Bi H; Guo D Biomed Pharmacother; 2021 Apr; 136():111291. PubMed ID: 33493870 [TBL] [Abstract][Full Text] [Related]
3. Activation of the Notch signaling pathway disturbs the CD4 Yin X; Liu B; Wei H; Wu S; Guo L; Xu F; Liu T; Bi H; Guo D Inflamm Res; 2019 Sep; 68(9):761-774. PubMed ID: 31209505 [TBL] [Abstract][Full Text] [Related]
4. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU). Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639 [TBL] [Abstract][Full Text] [Related]
5. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis. Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657 [TBL] [Abstract][Full Text] [Related]
6. Oral administration of retinoic acid receptor-alpha/beta-specific ligand Am80 suppresses experimental autoimmune uveoretinitis. Keino H; Watanabe T; Sato Y; Okada AA Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1548-56. PubMed ID: 20861477 [TBL] [Abstract][Full Text] [Related]
7. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats]. Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771 [TBL] [Abstract][Full Text] [Related]
8. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6. Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802 [TBL] [Abstract][Full Text] [Related]
9. Imbalance Between Th17 Cells and Regulatory T Cells During Monophasic Experimental Autoimmune Uveitis. Zhang L; Wan F; Song J; Tang K; Zheng F; Guo J; Guo D; Bi H Inflammation; 2016 Feb; 39(1):113-122. PubMed ID: 26296290 [TBL] [Abstract][Full Text] [Related]
10. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis. Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173 [TBL] [Abstract][Full Text] [Related]
11. Dynamics of intraocular IFN-γ, IL-17 and IL-10-producing cell populations during relapsing and monophasic rat experimental autoimmune uveitis. Kaufmann U; Diedrichs-Möhring M; Wildner G PLoS One; 2012; 7(11):e49008. PubMed ID: 23155443 [TBL] [Abstract][Full Text] [Related]
12. Reactivation of uveitogenic T cells by retinal astrocytes derived from experimental autoimmune uveitis-prone B10RIII mice. Jiang G; Ke Y; Sun D; Han G; Kaplan HJ; Shao H Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):282-9. PubMed ID: 18172104 [TBL] [Abstract][Full Text] [Related]
13. Effector T cells driving monophasic vs. relapsing/remitting experimental autoimmune uveitis show unique pathway signatures. von Toerne C; Sieg C; Kaufmann U; Diedrichs-Möhring M; Nelson PJ; Wildner G Mol Immunol; 2010; 48(1-3):272-80. PubMed ID: 20727594 [TBL] [Abstract][Full Text] [Related]
14. Ocular regulatory T cells distinguish monophasic from recurrent autoimmune uveitis. Ke Y; Jiang G; Sun D; Kaplan HJ; Shao H Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):3999-4007. PubMed ID: 18487362 [TBL] [Abstract][Full Text] [Related]
15. Differentially expressed genes in MHC-compatible rat strains that are susceptible or resistant to experimental autoimmune uveitis. Mattapallil MJ; Augello A; Cheadle C; Teichberg D; Becker KG; Chan CC; Mattapallil JJ; Pennesi G; Caspi RR Invest Ophthalmol Vis Sci; 2008 May; 49(5):1957-70. PubMed ID: 18281616 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity. Zhang X; Ren X; Li G; Jiao C; Zhang L; Zhao S; Wang J; Han ZC; Li X Invest Ophthalmol Vis Sci; 2011 May; 52(6):3143-52. PubMed ID: 21296818 [TBL] [Abstract][Full Text] [Related]
17. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation. Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009 [TBL] [Abstract][Full Text] [Related]
18. Induction of antigen-specific Treg cells in treating autoimmune uveitis via bystander suppressive pathways without compromising anti-tumor immunity. Chen Z; Zhang T; Kam HT; Qiao D; Jin W; Zhong Y; Zhou M; Zhou H; Chong WP; Chen W; Chen J EBioMedicine; 2021 Aug; 70():103496. PubMed ID: 34280776 [TBL] [Abstract][Full Text] [Related]
19. Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats. Fang CB; Zhou DX; Zhan SX; He Y; Lin Z; Huang C; Li J PLoS One; 2013; 8(4):e62071. PubMed ID: 23626769 [TBL] [Abstract][Full Text] [Related]
20. Regulatory role of TLR ligands on the activation of autoreactive T cells by retinal astrocytes. Jiang G; Ke Y; Sun D; Wang Y; Kaplan HJ; Shao H Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4769-76. PubMed ID: 19443727 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]